Using Statistics to Improve the Quality of Genomic and Proteomic Data.

Reports on the use of statistics to improve the quality of genomic and proteomic data analysis for the pharmaceutical and biotechnology industry. Expectation of the approach to yield alternative biomarkers and improve the efficiency of the drug discovery process; Identification of sources for variability; Identification and removal of batch effects through microgram processes; Procedure for collecting quality data from genomic and proteomic-based platforms.